18 results
6-K
EX-99.5
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
the period
Codes
Total
1. Men
2. Women
Average number of employees
Full-time
Part-time
Total in full-time equivalents (FTE)
Number of actual hours worked … . Women
Average number of employees in FTE
Number of actual hours worked
Personnel costs
Benefits in addition to wages
54/57
N°.
F-cap 10
EMPLOYEES
6-K
EX-99.2
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
for a term of four years. In 2023, the Board of Directors thus consisted of three women (except between 12 June 2023 and 18 September 2023 when … the Board consisted of four women), and six men (except between 12 June 2023 and 18 September 2023 when the Board consisted of five men), representing
6-K
EX-99.1
GLPG
Galapagos NV
30 Aug 23
Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with active systemic lupus erythematosus
6:31am
that primarily target a variety of nuclear antigens, deposit in tissues and activate complement, resulting in organ damage. SLE affects women more frequently
6-K
EX-99.1
ovil7f5iv
28 May 21
Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress
6:00am
6-K
EX-99.1
f5equr84f4xgmzzjqx
19 May 21
Current report (foreign)
6:00am
6-K
EX-99.1
egndmdwl4tt
23 Apr 21
Current report (foreign)
6:05am
6-K
EX-99
s72wxq6ef2 v1aca8l
4 Apr 17
Galapagos announces three new Phase 2 Proof-of-Concept studies with filgotinib
12:00am
6-K
EX-99.1
psza m1il5zyq
22 Apr 16
Galapagos reports additional data with filgotinib from the Phase 2 FITZROY study
12:00am
20-F
fnrg5m
25 Mar 16
Annual report (foreign)
12:00am
DRS
EX-10
0789afk5l8d8w6l779
6 Feb 15
Draft registration statement
12:00am
DRS
eu3bk agtd
6 Feb 15
Draft registration statement
12:00am
- Prev
- 1
- Next